Original Publication Date: 1 October, 2015
Publication / Source: Future Oncology
Authors: Ismail Jatoi
Ironically, improvements in breast cancer therapy and screening technology are very likely diminishing the benefit of mammography screening. Therapeutic advances are reducing both the relative and absolute benefit of mammography screening on breast cancer specific mortality, while advances in imaging technology are increasing the risk of overdiagnosis and hence the risk of a small excess in mortality from unnecessary diagnostic and therapeutic interventions. Alternatives to mammography screening should be considered, particularly in older women, for whom the risk of overdiagnosis is substantial.